Gain-of-function of STING shows significant analgesic effects in naïve mice as well as in preclinical models of chemotherapy-induced painful polyneuropathy (CIPN), peripheral nerve constriction injury, and bone cancer pain. The gene discussed is STING1; the disease is bone neoplasm.